Skip to main content
Figure 2 | BMC Gastroenterology

Figure 2

From: Retreatment of hepatitis C non-responsive to Interferon. A placebo controlled randomized trial of Ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378]

Figure 2

Cumulative probability of ALT response during treatment. Intention to treat population, per treatment group. Response was defined as normal ALT on at least two sequential occasions, the time of response was taken at the first normal ALT. p = 0,00 interferon + ribavirin vs placebo p = 0,02 ribavirin vs placebo p = 0,02 interferon + ribavirin vs ribavirin (Log rank test)

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us